AR031674A1 - Composicion farmaceutica que comprende un sensibilizador de insulina en combinacion con otro compuesto farmaceuticamente activo y uso de dicho sensibilizador en combinacion con otro compuesto farmaceuticamente activo para fabricarla - Google Patents
Composicion farmaceutica que comprende un sensibilizador de insulina en combinacion con otro compuesto farmaceuticamente activo y uso de dicho sensibilizador en combinacion con otro compuesto farmaceuticamente activo para fabricarlaInfo
- Publication number
- AR031674A1 AR031674A1 ARP000104514A ARP000104514A AR031674A1 AR 031674 A1 AR031674 A1 AR 031674A1 AR P000104514 A ARP000104514 A AR P000104514A AR P000104514 A ARP000104514 A AR P000104514A AR 031674 A1 AR031674 A1 AR 031674A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- compound
- salt
- pharmaceutical composition
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25044399 | 1999-09-03 | ||
JP2000056021 | 2000-02-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR031674A1 true AR031674A1 (es) | 2003-10-01 |
Family
ID=26539777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000104514A AR031674A1 (es) | 1999-09-03 | 2000-08-30 | Composicion farmaceutica que comprende un sensibilizador de insulina en combinacion con otro compuesto farmaceuticamente activo y uso de dicho sensibilizador en combinacion con otro compuesto farmaceuticamente activo para fabricarla |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1212090A2 (fr) |
KR (1) | KR20020063555A (fr) |
CN (1) | CN1372476A (fr) |
AR (1) | AR031674A1 (fr) |
AU (1) | AU6868000A (fr) |
CA (1) | CA2383946A1 (fr) |
CO (1) | CO5180632A1 (fr) |
HK (1) | HK1044711A1 (fr) |
HU (1) | HUP0203285A3 (fr) |
NO (1) | NO20021036L (fr) |
PE (1) | PE20010580A1 (fr) |
PL (1) | PL354295A1 (fr) |
RU (1) | RU2002108346A (fr) |
WO (1) | WO2001017513A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1354602B1 (fr) * | 2000-12-26 | 2006-10-04 | Sankyo Company, Limited | Compositions medicinales contenant un diuretique et un agent renforcant la resistance a l'insuline |
CN100577175C (zh) | 2001-04-04 | 2010-01-06 | 奥索-麦克尼尔药品公司 | 包括葡萄糖重吸收抑制剂和ppar调节剂的联合疗法 |
US6838442B2 (en) | 2001-04-04 | 2005-01-04 | Ortho-Mcneil Pharmaceutical, Inc. | Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators |
FR2838968A1 (fr) * | 2002-04-30 | 2003-10-31 | Lipha | Association d'insuline et d'un derive de thiazolidinedione et son utilisation pour traiter le diabete |
EP1514869A1 (fr) * | 2002-06-12 | 2005-03-16 | Sumitomo Pharmaceuticals Company, Limited | Indole, indazole, et derive benzazole |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04501722A (ja) * | 1988-11-14 | 1992-03-26 | ジ・アップジョン・カンパニー | 抗―糖尿病、抗―肥満症および抗―アテローム性動脈硬化症薬として有用なα―アミノ―インドール―3―酢酸 |
KR0170416B1 (ko) * | 1990-02-09 | 1999-02-18 | 로버트 에이. 아미테이지 | 고혈압 치료를 위한 인슐린 증감제의 용도 |
JP3100165B2 (ja) * | 1994-11-29 | 2000-10-16 | 大日本製薬株式会社 | インドール誘導体 |
-
2000
- 2000-08-29 PE PE2000000887A patent/PE20010580A1/es not_active Application Discontinuation
- 2000-08-30 AR ARP000104514A patent/AR031674A1/es not_active Application Discontinuation
- 2000-09-01 EP EP00956872A patent/EP1212090A2/fr not_active Withdrawn
- 2000-09-01 WO PCT/JP2000/005951 patent/WO2001017513A2/fr not_active Application Discontinuation
- 2000-09-01 HU HU0203285A patent/HUP0203285A3/hu unknown
- 2000-09-01 CO CO00065981A patent/CO5180632A1/es not_active Application Discontinuation
- 2000-09-01 RU RU2002108346/14A patent/RU2002108346A/ru not_active Application Discontinuation
- 2000-09-01 CN CN00812420A patent/CN1372476A/zh active Pending
- 2000-09-01 KR KR1020027002851A patent/KR20020063555A/ko not_active Application Discontinuation
- 2000-09-01 PL PL00354295A patent/PL354295A1/xx not_active Application Discontinuation
- 2000-09-01 CA CA002383946A patent/CA2383946A1/fr not_active Abandoned
- 2000-09-01 AU AU68680/00A patent/AU6868000A/en not_active Abandoned
-
2002
- 2002-03-01 NO NO20021036A patent/NO20021036L/no not_active Application Discontinuation
- 2002-08-15 HK HK02105969.4A patent/HK1044711A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
PE20010580A1 (es) | 2001-05-25 |
WO2001017513A2 (fr) | 2001-03-15 |
EP1212090A2 (fr) | 2002-06-12 |
CO5180632A1 (es) | 2002-07-30 |
AU6868000A (en) | 2001-04-10 |
WO2001017513A3 (fr) | 2001-09-20 |
KR20020063555A (ko) | 2002-08-03 |
RU2002108346A (ru) | 2003-11-20 |
CN1372476A (zh) | 2002-10-02 |
CA2383946A1 (fr) | 2001-03-15 |
HUP0203285A2 (hu) | 2003-01-28 |
HUP0203285A3 (en) | 2003-02-28 |
NO20021036L (no) | 2002-04-26 |
NO20021036D0 (no) | 2002-03-01 |
HK1044711A1 (zh) | 2002-11-01 |
PL354295A1 (en) | 2004-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2935035T3 (es) | Compuestos de benzofuranilo y benzoxazolilo sustituídos y usos farmacéuticos de los mismos | |
AR118805A2 (es) | Terapia de combinación para el tratamiento de la diabetes | |
AU2016372028B2 (en) | Methods of treating hyperalgesia | |
NO20074012L (no) | 1-tio-D-glucitolderivater | |
DE602007009420D1 (de) | Oxadiazolderivate als s1p1-rezeptor-agonisten | |
PE20081487A1 (es) | DERIVADOS DE NICOTINAMIDA COMO INHIBIDORES DE 11ßHSD1 | |
PE20081228A1 (es) | Compuesto heteromonociclico | |
JP2010536882A5 (fr) | ||
PE20070833A1 (es) | Compuestos de pirimidinil benzotiofeno | |
EA200602260A1 (ru) | Применение замещенных хинолиновых производных для лечения заболеваний, вызываемых микобактериями, резистентными к лекарственным средствам | |
BRPI0506765A (pt) | composto ou um seu sal, hidrato e/ou pró-droga farmaceuticamente aceitáveis, composição farmacêutica, métodos para inibir a produção de beta-amilóide em um paciente e para tratar de uma doença, kit farmacêutico, uso de um composto ou de uma composição | |
GEP20094727B (en) | Oxyindole derivatives as 5ht4 receptor agonists | |
NO20075723L (no) | Tiazolforbindelser og fremgangsmater for anvendelse | |
AR029469A1 (es) | Compuesto de azaindol, compuesto de azaindol de utilidad como intermediario para preparar el anterior, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima | |
JP2010506942A5 (fr) | ||
BRPI0707718A2 (pt) | uso de um composto | |
AR069772A1 (es) | Derivados heterociclicos, una composicion farmaceutica y un juego que los comprenden y su uso en la preparacion de un medicamento para el tratamiento de una infeccion parasitaria. | |
JP2007527904A5 (fr) | ||
CN102656164A (zh) | 作为结核病抑制剂的嘧啶化合物 | |
NO20051901L (no) | Nye antimycobakterielle sammensetninger og pyrrole derivater som antimycobakterielle sammensetninger | |
Testai et al. | Cardiac ATP-sensitive potassium channels: a potential target for an anti-ischaemic pharmacological strategy | |
JP2015178458A (ja) | ベンゼン環縮合含窒素5員複素環式化合物、またはその薬理学的に許容される塩 | |
NO20051900L (no) | Kinazolinderivater som SRC tyrosin kinase inhibitorer | |
EP3129375A1 (fr) | Inhibiteurs d'asparagine endopeptidase (aep) pour la prise en charge du cancer et compositions associées | |
IE60707B1 (en) | Pharmacologically active substituted benzamides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |